These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12672615)

  • 21. A drug release study from hydroxypropylmethylcellulose (HPMC) matrices using QSPR modeling.
    Ghafourian T; Safari A; Adibkia K; Parviz F; Nokhodchi A
    J Pharm Sci; 2007 Dec; 96(12):3334-51. PubMed ID: 17626286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets.
    Asnaashari S; Khoei NS; Zarrintan MH; Adibkia K; Javadzadeh Y
    Pharm Dev Technol; 2011 Aug; 16(4):400-7. PubMed ID: 20429828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D; Vrečer F
    Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of HPMC substituent pattern on water up-take, polymer and drug release: An experimental and modelling study.
    Caccavo D; Lamberti G; Barba AA; Abrahmsén-Alami S; Viridén A; Larsson A
    Int J Pharm; 2017 Aug; 528(1-2):705-713. PubMed ID: 28636894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of sustained-release propranolol dosage form using factorial design and response surface methodology.
    Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC
    Biol Pharm Bull; 2004 Oct; 27(10):1626-9. PubMed ID: 15467208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].
    Zhang Y; Huang G; Yu Y; Han J; Yu P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):597-600, 614. PubMed ID: 16856397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous quantification of drug release and erosion from hypromellose hydrophilic matrices.
    Ghori MU; Ginting G; Smith AM; Conway BR
    Int J Pharm; 2014 Apr; 465(1-2):405-12. PubMed ID: 24560637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E; Georgarakis E; Bikiaris D
    Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of drug solubility on the release of slightly water-soluble drugs from HPMC matrices.
    Fu XC; Liang WQ; Wang GP
    Pharmazie; 2003 May; 58(5):355-6. PubMed ID: 12779057
    [No Abstract]   [Full Text] [Related]  

  • 32. Preparation and evaluation of gastroretentive floating tablets of Silymarin.
    Garg R; Gupta GD
    Chem Pharm Bull (Tokyo); 2009 Jun; 57(6):545-9. PubMed ID: 19483331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS; Saha RN
    Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of drug release from hydroxypropyl methylcellulose (HPMC) matrices: effect of polymer concentration.
    Shah N; Zhang G; Apelian V; Zeng F; Infeld MH; Malick AW
    Pharm Res; 1993 Nov; 10(11):1693-5. PubMed ID: 8290487
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mathematical modeling of drug release profiles for modified hydrophobic HPMC based gels.
    Ghosal K; Chandra A; Rajabalaya R; Chakraborty S; Nanda A
    Pharmazie; 2012 Feb; 67(2):147-55. PubMed ID: 22512085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A; Millán M; Caraballo I
    J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
    Chakraborty S; Khandai M; Sharma A; Patra ChN; Patro VJ; Sen KK
    Acta Pharm; 2009 Sep; 59(3):313-23. PubMed ID: 19819827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
    Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
    Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.